Forskning ved Københavns Universitet - Københavns Universitet

Forside

The Ethics of Synthetic Biology: Respecting Life and Managing Risk

Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

Standard

The Ethics of Synthetic Biology : Respecting Life and Managing Risk. / Christiansen, Andreas.

Det Humanistiske Fakultet, Københavns Universitet, 2016. 221 s.

Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

Harvard

Christiansen, A 2016, The Ethics of Synthetic Biology: Respecting Life and Managing Risk. Det Humanistiske Fakultet, Københavns Universitet.

APA

Christiansen, A. (2016). The Ethics of Synthetic Biology: Respecting Life and Managing Risk. Det Humanistiske Fakultet, Københavns Universitet.

Vancouver

Christiansen A. The Ethics of Synthetic Biology: Respecting Life and Managing Risk. Det Humanistiske Fakultet, Københavns Universitet, 2016. 221 s.

Author

Christiansen, Andreas. / The Ethics of Synthetic Biology : Respecting Life and Managing Risk. Det Humanistiske Fakultet, Københavns Universitet, 2016. 221 s.

Bibtex

@phdthesis{9627a255f819451eba8f5e169bfbb793,
title = "The Ethics of Synthetic Biology: Respecting Life and Managing Risk",
abstract = "The dissertation analyses and discusses a number of ethical issues that have been raised in connection with the development of synthetic biology. Synthetic biology is a set of new techniques for DNA-level design and construction of living beings with useful properties. The dissertation especially focuses on two aspects:1. New biotechnologies are typically met by a set of objections that are simultaneously very common and very vague; e.g. that manipulating the genome is {\textquoteleft}unnatural{\textquoteright} or that it amounts to {\textquoteleft}playing god{\textquoteright}. I discuss how these objections are best understood, whether (or to what extent) popular responsesto them succeed, and whether the objections are ultimately persuasive.2. Given that synthetic biology is a new technology, there is a certain degree of uncertainty about its ultimate effects, and many perceive the technology as risky. I discuss two common approaches in risk regulation, namely the precautionary principle and cost-benefit analysis. I argue that the precautionary principle is more reasonable than it is frequently given credit for, and that cost-benefit analysis cannot be defended as the uniquely rational decision procedure.",
author = "Andreas Christiansen",
year = "2016",
language = "English",
publisher = "Det Humanistiske Fakultet, K{\o}benhavns Universitet",
address = "Denmark",

}

RIS

TY - BOOK

T1 - The Ethics of Synthetic Biology

T2 - Respecting Life and Managing Risk

AU - Christiansen, Andreas

PY - 2016

Y1 - 2016

N2 - The dissertation analyses and discusses a number of ethical issues that have been raised in connection with the development of synthetic biology. Synthetic biology is a set of new techniques for DNA-level design and construction of living beings with useful properties. The dissertation especially focuses on two aspects:1. New biotechnologies are typically met by a set of objections that are simultaneously very common and very vague; e.g. that manipulating the genome is ‘unnatural’ or that it amounts to ‘playing god’. I discuss how these objections are best understood, whether (or to what extent) popular responsesto them succeed, and whether the objections are ultimately persuasive.2. Given that synthetic biology is a new technology, there is a certain degree of uncertainty about its ultimate effects, and many perceive the technology as risky. I discuss two common approaches in risk regulation, namely the precautionary principle and cost-benefit analysis. I argue that the precautionary principle is more reasonable than it is frequently given credit for, and that cost-benefit analysis cannot be defended as the uniquely rational decision procedure.

AB - The dissertation analyses and discusses a number of ethical issues that have been raised in connection with the development of synthetic biology. Synthetic biology is a set of new techniques for DNA-level design and construction of living beings with useful properties. The dissertation especially focuses on two aspects:1. New biotechnologies are typically met by a set of objections that are simultaneously very common and very vague; e.g. that manipulating the genome is ‘unnatural’ or that it amounts to ‘playing god’. I discuss how these objections are best understood, whether (or to what extent) popular responsesto them succeed, and whether the objections are ultimately persuasive.2. Given that synthetic biology is a new technology, there is a certain degree of uncertainty about its ultimate effects, and many perceive the technology as risky. I discuss two common approaches in risk regulation, namely the precautionary principle and cost-benefit analysis. I argue that the precautionary principle is more reasonable than it is frequently given credit for, and that cost-benefit analysis cannot be defended as the uniquely rational decision procedure.

M3 - Ph.D. thesis

BT - The Ethics of Synthetic Biology

PB - Det Humanistiske Fakultet, Københavns Universitet

ER -

ID: 169757718